中国综合临床
中國綜閤臨床
중국종합림상
CLINICAL MEDICINE OF CHINA
2011年
3期
312-314
,共3页
谈宜傲%周林玉%石结武%诸禹平%宋洪斌%吴畏%黄昆
談宜傲%週林玉%石結武%諸禹平%宋洪斌%吳畏%黃昆
담의오%주림옥%석결무%제우평%송홍빈%오외%황곤
ⅢA型前列腺炎%综合治疗
ⅢA型前列腺炎%綜閤治療
ⅢA형전렬선염%종합치료
Type Ⅲ A prostatitis%Comprehensive treatment
目的 探讨综合治疗ⅢA型前列腺炎的疗效.方法 选择符合国立卫生研究院(NIH)诊断标准的ⅢA型前列腺炎患者184例,采用口服抗生素和α1受体阻滞剂、吲哚美辛栓纳肛及前列腺按摩和心理疏导综合治疗,疗程8～12周.以NIH慢性前列腺炎症状指数(CPSI)评分和前列腺液(EPS)常规白细胞计数为指标评价疗效比较.结果 NIH-CPSI总评分治疗前后分别为(28.6±6.5)分和(12.9±3.8)分(t=28.3、P＜0.05);疼痛或不适评分治疗前后分别为(14.1±3.3)分和(6.4±2.2)分(t=26.3,P＜0.05);排尿症状评分治疗前后分别为(5.6±1.8)分和(2.1±0.9)分(t=23.6,P＜0.05);生活质量评分治疗前后分别为(8.9±3.1)分和(4.4±2.4)分(t=15.6,P＜0.05);EPS中白细胞计数治疗前后分别为(24.5±4.4)个/HP和(6.2±2.7)个/HP(t=48.1P＜0.05).治愈79例,显效57例,有效36例,无效12例,总有效率93.5%.结论 综合治疗ⅢA型前列腺炎疗效较好.
目的 探討綜閤治療ⅢA型前列腺炎的療效.方法 選擇符閤國立衛生研究院(NIH)診斷標準的ⅢA型前列腺炎患者184例,採用口服抗生素和α1受體阻滯劑、吲哚美辛栓納肛及前列腺按摩和心理疏導綜閤治療,療程8～12週.以NIH慢性前列腺炎癥狀指數(CPSI)評分和前列腺液(EPS)常規白細胞計數為指標評價療效比較.結果 NIH-CPSI總評分治療前後分彆為(28.6±6.5)分和(12.9±3.8)分(t=28.3、P＜0.05);疼痛或不適評分治療前後分彆為(14.1±3.3)分和(6.4±2.2)分(t=26.3,P＜0.05);排尿癥狀評分治療前後分彆為(5.6±1.8)分和(2.1±0.9)分(t=23.6,P＜0.05);生活質量評分治療前後分彆為(8.9±3.1)分和(4.4±2.4)分(t=15.6,P＜0.05);EPS中白細胞計數治療前後分彆為(24.5±4.4)箇/HP和(6.2±2.7)箇/HP(t=48.1P＜0.05).治愈79例,顯效57例,有效36例,無效12例,總有效率93.5%.結論 綜閤治療ⅢA型前列腺炎療效較好.
목적 탐토종합치료ⅢA형전렬선염적료효.방법 선택부합국립위생연구원(NIH)진단표준적ⅢA형전렬선염환자184례,채용구복항생소화α1수체조체제、신타미신전납항급전렬선안마화심리소도종합치료,료정8～12주.이NIH만성전렬선염증상지수(CPSI)평분화전렬선액(EPS)상규백세포계수위지표평개료효비교.결과 NIH-CPSI총평분치료전후분별위(28.6±6.5)분화(12.9±3.8)분(t=28.3、P＜0.05);동통혹불괄평분치료전후분별위(14.1±3.3)분화(6.4±2.2)분(t=26.3,P＜0.05);배뇨증상평분치료전후분별위(5.6±1.8)분화(2.1±0.9)분(t=23.6,P＜0.05);생활질량평분치료전후분별위(8.9±3.1)분화(4.4±2.4)분(t=15.6,P＜0.05);EPS중백세포계수치료전후분별위(24.5±4.4)개/HP화(6.2±2.7)개/HP(t=48.1P＜0.05).치유79례,현효57례,유효36례,무효12례,총유효솔93.5%.결론 종합치료ⅢA형전렬선염료효교호.
Objective To study the efficacy of comprehensive treatment for type ⅢA prostatitis.Methods One hundred and eighty-four patients with type Ⅲ A prostatitis, recruited to this study, were comprehensively treated for 8 - 12 weeks by oral antibiotics and α-1 receptor antagonist,indometacin suppository applied into rectal, prostate massage and psychological counseling. The clinical effects of the treatment were evaluated according to the NIH chronic prostatitis symptom index (NIH-CPSI) and leukocyte counts in the expressed prostatic secretions ( EPS ). Results Before and after the treatment, the NIH-CPSI scores were 28. 6 ± 6. 5 and 12. 9 ± 3. 8 ( t = 28. 3, P ＜ 0. 05 ); the pain or discomfort scores were 14. 1 ± 3. 3 and 6. 4 ± 2.2( t = 26. 3, P ＜ 0. 05 ), the urinary symptoms scores were 5.6 ± 1.8 and 2. 1 ± 0. 9 ( t = 23.6, P ＜ 0. 05 ), the scores of life quality were 8.9 ± 3. 1 and 4. 4 ± 2.4 ( t = 15.6, P ＜ 0. 05 ), the leukocyte counts were ( 24. 5 ±4. 4)/HP and ( 6. 2 ± 2. 7 )/HP ( t = 48.1, P ＜ 0. 05 ) respectively, all comparisons showed significantly differences. Seventy-nine cases recovered completely, 57 cases recovered excellently, 36 cases recovered effectively and 12 cases did not recover, the overall effective rate was 93.5%. Conclusion Comprehensive treatment is an effective method for type Ⅲ A prostatitis.
